Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (171-180 of 318) with videos related to

Pageof 32
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 12, 2020
Large-scale characterization of the microvascular geometry in development and disease by tissue clearing and quantitative ultramicroscopyArtur Hahn, Julia Bode, Allen Alexander, et al.
The Journal of Clinical Investigation|January 3, 2015
Proximity ligation assay evaluates IDH1R132H presentation in gliomasLukas Bunse, Theresa Schumacher, Felix Sahm, et al.
Oncotarget|July 23, 2016
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapyDieter Lemke, Hans-Werner Pledl, Markus Zorn, et al.
American Journal of Respiratory and Critical Care Medicine|April 5, 2018
Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung CancerYoshikane Yamauchi, Seyer Safi, Carolin Blattner, et al.
Neuro-Oncology Practice|March 20, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 studyLinda Dirven, Abigirl Machingura, Martin J van den Bent, et al.
Neuro-Oncology Advances|January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trialAnnika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.
Science Advances|February 2, 2024
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patientTamara Boschert, Kristina Kromer, Taga Lerner, et al.
Oncoimmunology|January 27, 2017
The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomasJana K Sonner, Katrin Deumelandt, Martina Ott, et al.
Neuro-Oncology Advances|November 5, 2021
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodesJens Blobner, Michael Kilian, Chin Leng Tan, et al.
Oncotarget|March 25, 2014
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHRUlrike M Litzenburger, Christiane A Opitz, Felix Sahm, et al.
Pageof 32

Showing results (171-180 of 318) with videos related to

Sort By:
Pageof 32
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 12, 2020
Large-scale characterization of the microvascular geometry in development and disease by tissue clearing and quantitative ultramicroscopyArtur Hahn, Julia Bode, Allen Alexander, et al.
The Journal of Clinical Investigation|January 3, 2015
Proximity ligation assay evaluates IDH1R132H presentation in gliomasLukas Bunse, Theresa Schumacher, Felix Sahm, et al.
Oncotarget|July 23, 2016
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapyDieter Lemke, Hans-Werner Pledl, Markus Zorn, et al.
American Journal of Respiratory and Critical Care Medicine|April 5, 2018
Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung CancerYoshikane Yamauchi, Seyer Safi, Carolin Blattner, et al.
Neuro-Oncology Practice|March 20, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 studyLinda Dirven, Abigirl Machingura, Martin J van den Bent, et al.
Neuro-Oncology Advances|January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trialAnnika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.
Science Advances|February 2, 2024
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patientTamara Boschert, Kristina Kromer, Taga Lerner, et al.
Oncoimmunology|January 27, 2017
The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomasJana K Sonner, Katrin Deumelandt, Martina Ott, et al.
Neuro-Oncology Advances|November 5, 2021
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodesJens Blobner, Michael Kilian, Chin Leng Tan, et al.
Oncotarget|March 25, 2014
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHRUlrike M Litzenburger, Christiane A Opitz, Felix Sahm, et al.
Pageof 32